Replies to post #586710 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

It is far, far more rare and difficult to have a very successful drug moving toward approval that has the potential to be an agnostic cancer platform than to have a business generating large sums of cash from the sale of mediocre drugs.

Biosectinvestor, Thanks for this forest-from-the-trees statement. It's important to repeat because it is a concept that is important and requires time to sink in, for investors and the broader community.

Similarly I believe the same weight of significance applies to the concept that DCVax as a technology platform has potential to be a base layer foundation to "cure" cancers, on it's own or in combination with adjuvants, and in no small way because it is a truly autologous immunotherapy, efficacious, and with an almost no-toxicity profile.

These are major step changes in the field of cancer treatment that DCVax is about to make happen.